Propofol is an intravenous anaesthetic agent used for induction and maintenance of general anaesthesia. IV administration of propfol is used to induce unconsciousness after which anaesthesia may be maintained using a combination of medications. Recovery from propofol-induced anaesthesia is generally rapid and associated with less frequent side effects (e.g. drowsiness, nausea, vomiting) than with thiopental, methohexital, and etomidate. Propofol may be used prior to diagnostic procedures requiring anaesthesia, in the management of refractory status epilepticus, and for induction and/or maintenance of anaesthesia prior to and during surgeries.
Used for induction and/or maintenance of anaesthesia and for management of refractory status epilepticus.
UMCLjubljana, CD of Anaesthesiology and Intensive Therapy, Ljubljana, Slovenia
Anesthesiology and Reanimation Dept. Ordu University Training and Research Hospital, Altınordu, Ordu, Turkey
Yonsei university College of Medicine, Seoul, Korea, Republic of
Anesthesiology Department Hospital GU Gregorio Mrañón, Madrid, Spain
Yonsei University, Gangnam Severance Hospital, Seoul, Korea, Republic of
the First Hospital of China Medical University, Shenyang, Liaoning, China
Konkuk University Medical Center, Seoul, Korea, Republic of
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.